Clinical trial
Evaluation Of Linezolid Pk Profile In Burns Patients
NCT00255996 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00255996 |
|---|---|
| Title | Evaluation Of Linezolid Pk Profile In Burns Patients |
| Official title | An Open Label Parallel Group Study To Investigate The Pharmacokinetics Of Intravenous Linezolid, An Oxazolidinone, Administered To Healthy Volunteers And Patients With Major Thermal Injuries |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Burns |
| Intervention type | Drug |
| Interventions | linezolid |
| Enrollment | 16 |
| Start date | May 1, 2006 |
| Completion | Jan 1, 2007 |
| First posted | Nov 21, 2005 |
| Last update posted | Jul 14, 2009 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: